Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Internal and external Web-based communities are changing how pharma companies can innovate.

Web 2.0 for Pharma Innovation

The author offers perspectives on ways in which pharmaceutical companies and other stakeholders in the supply chain can confront the threat of counterfeit products, cargo theft, illegal diversion, and economically motivated adulteration.

A Pharmaceutical Company's View on Supply-Chain Security: A Perspective from Pfizer

Might European officials reverse their position on acceptable production methods?

Regulators Debate Methods for Producing Water for Injection

The third in a series of eight case studies from the Product Quality Research Institute focuses on facility biocontainment and inactivation.

PQRI Case Study (3): Facility Biocontainment and Inactivation

Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies.

Building Toolboxes in Pursuit of Single-Enantiomer Drugs

David Edwards is Director of Pharmaceutical Technology at Capsugel.

Direct dosing APIs during R&D studies can reduce the overall testing time of a drug candidate by allowing for a greater throughput of compounds through the R&D department.

Improving R&D with API microdosing

The increasing cost of crucial manufacturing input factors, such as energy and raw materials, has been a severe threat to several companies.

API Market Challenges

Elham Blouet is Pharmaceutical Project & Development Manager, Pharmaceuticals & Cosmetics BU, at Roquette.

Elham Blouet from Roquette explains the importance of carbohydrates for injection and the challenges in this niche market.

Carbohydrates For Injection

The authors desribe the three-stage approach to validation that is outlined in the new guidance and discuss questions surrounding implementation.

FDA's New Process Validation Guidance: Industry Reaction, Questions, and Challenges

Dr. Andreas Stolle is head of business line pharma at Saltigo GmbH.

The increased trend of outsourcing coupled with a relatively strong economy has seen the fine chemicals market grow at a very high level when compared to historical data.

Ingredients